MedTrace Logo

Effect of the MobiusHD® in Patients With Heart Failure

NCT04590001 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-02-14

No results posted yet for this study

Summary

This is a prospective, multi-center, open-label clinical trial intended to evaluate the safety and effectiveness of the MobiusHD® in patients with heart failure and reduced ejection fraction.

Conditions

  • Heart Failure With Reduced Ejection Fraction

Interventions

DEVICE

MobiusHD

The MobiusHD device is a nickel-titanium device that is implanted in the internal carotid sinus using a minimally invasive approach.

Sponsors & Collaborators

  • Vascular Dynamics, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-02
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • Australia
  • Canada
  • Georgia
  • Germany
  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590001 on ClinicalTrials.gov